Sustainable Pricing in Diabetes: Cost-Effective...

By HEOR Staff Writer

May 9, 2024

Introduction: The escalating burden of diabetes across the globe is a clarion call for a re-evaluation of medication pricing. With an est...
Medical Diagnostics: The Meeting Point of AI and Policies
Biosimilar Competition and Patient Out-of-Pocket Costs
Managing Access to Medicines in the Future: Innovations and Strategies
Fast-Track City Program Impact: Accelerating the End of AIDS
Cancer Care and the Importance of AI in Furthering Oncology
Life Sciences Summit Finalists Set to Transform Healthcare
AI’s Transformative Role in Healthcare: Code of Conduct
A Cost-Effectiveness Analysis of Emicizumab Treatment in Non-Severe Haemophil...
Policy of Innovative Health Technology: Biobanks in Abu Dhabi
Evaluating the Impact of Molnupiravir in COVID-19 Treatment
AI in Healthcare Value Creation and Competitive Advantage
Strategic Cost Implications of Medical Countermeasure Stockpiling